Abstract: An impedance-based respiration monitoring system for apnea detection includes at least three surface electrodes configured to record impedance respiration data from a patient's torso, a signal processing system, and an apnea detection module. The signal processing system is configured to generate a first respiration lead formed by a first set of surface electrodes from the at least three surface electrodes, the first respiration lead providing a first series of impedance measurements, and to generate a second respiration lead formed by a second set of surface electrodes attached to the patient's torso, the second lead providing a second series of impedance measurements. The apnea detection module is executable on a processor to calculate a first apnea metric based on the first series of impedance measurements, and calculate a second apnea metric based on the second series of impedance measurements. An apnea event is then detected based on the first apnea metric and the second apnea metric.

Abstract: An impedance-based respiration monitoring system for apnea detection includes at least three surface electrodes configured to record impedance respiration data from a patient's torso, a signal processing system, and an apnea detection module. The signal processing system is configured to generate a first respiration lead formed by a first set of surface electrodes from the at least three surface electrodes, the first respiration lead providing a first series of impedance measurements, and to generate a second respiration lead formed by a second set of surface electrodes attached to the patient's torso, the second lead providing a second series of impedance measurements. The apnea detection module is executable on a processor to calculate a first apnea metric based on the first series of impedance measurements, and calculate a second apnea metric based on the second series of impedance measurements. An apnea event is then detected based on the first apnea metric and the second apnea metric.

Abstract: An apparatus comprising a monitor, a blood pressure measuring device, and a controller. The monitor is configured to estimate a blood pressure of a patient. The blood pressure measuring device is configured to measure a blood pressure of the patient. The controller is operatively coupled to the monitor and to the blood pressure measuring device. The controller is configured to cause the blood pressure measuring device to take a first blood pressure measurement of the patient in response to an estimated blood pressure deviating from a baseline. The controller is also configured to cause the blood pressure measuring device to take a second blood pressure measurement of the patient in response to an estimated blood pressure deviating from a second baseline different than the first baseline.

Abstract: A system for measuring ECG data and respiratory data for a patient. The system includes at least four ECG wires configured to communicate a first set of cardiac electrical activity from the patient. A respiratory wire distinct from the at least four ECG wires is configured to communicate respiratory electrical activity from the patient. An electronics device is electrically coupled to the at least four ECG wires and to the respiratory wire. The electronics device is configured to measure the ECG data based on the first set of cardiac electrical activity from the at least four ECG wires, and to measure the respiratory data based on the respiratory electrical activity from the respiratory wire.

Abstract: A system for monitoring medical conditions includes a conformable medical monitoring device that includes a first substrate layer, which includes an electronics module, many signal traces, and at least one electrode, such that one or more of the many signal traces electrically couple the at least one electrode to the electronics module. The conformable medical monitoring device includes a second substrate layer positioned over the electronics module, the first substrate layer, or any combination thereof to insulate the electronics module, the first substrate layer, or any combination thereof. The conformable medical monitoring device also includes a third substrate layer positioned over the second substrate layer, such that the third substrate layer reduces electromagnetic interference caused by a voltage pulse and includes an adjustable system coupled to the first substrate layer and that changes a position of the at least one electrode relative to the electronics module.

Abstract: An arrangement of a RFID label (100), the RFID label comprising a chip (3), an antenna (1) coupled to the chip, an RFID inlay (6), and an antenna extender label (7), the antenna extender label being attached to the RFID inlay, and comprising an extender antenna (8), and a RF coupling element (9) arranged to couple with the antenna. At least part of the antenna extender label is attached removably to the RFID inlay such that the extender antenna is detachable from the RFID label without destroying the transmission capability of the antenna.

Abstract: An arrangement of a RFID label (100), the RFID label comprising a chip (3), an antenna (1) coupled to the chip, an RFID inlay (6), and an antenna extender label (7), the antenna extender label being attached to the RFID inlay, and comprising an extender antenna (8), and a RF coupling element (9) arranged to couple with the antenna. At least part of the antenna extender label is attached removably to the RFID inlay such that the extender antenna is detachable from the RFID label without destroying the transmission capability of the antenna.

Abstract: A reflective SpO2 measurement system includes a light source that emits light of at least a first and second wavelengths, and one or more detection devices forming a close detector positioned at a first distance from the light source and a far detector positioned at a second distance from the light source, wherein the second distance is greater than the first. The SpO2 measurement system is configured to operate in a high power mode to determine a calibration factor based on the comparison of light reflections detected by the close detector and the far detector. The system is further configured to operate in a low power mode to generate a low intensity light pulse, and detect a close reflection of the low intensity light pulse with the close detector. An SpO2 is then determined based on the close reflection of the low intensity light pulse and the calibration factor.

Abstract: An impedance-based respiration monitoring system for apnea detection includes at least three surface electrodes configured to record impedance respiration data from a patient's torso, a signal processing system, and an apnea detection module. The signal processing system is configured to generate a first respiration lead formed by a first set of surface electrodes from the at least three surface electrodes, the first respiration lead providing a first series of impedance measurements, and to generate a second respiration lead formed by a second set of surface electrodes attached to the patient's torso, the second lead providing a second series of impedance measurements. The apnea detection module is executable on a processor to calculate a first apnea metric based on the first series of impedance measurements, and calculate a second apnea metric based on the second series of impedance measurements. An apnea event is then detected based on the first apnea metric and the second apnea metric.

Abstract: A reflective SpO2 measurement system includes a light source that emits light of at least a first and second wavelengths, and one or more detection devices forming a close detector positioned at a first distance from the light source and a far detector positioned at a second distance from the light source, wherein the second distance is greater than the first. The SpO2 measurement system is configured to operate in a high power mode to determine a calibration factor based on the comparison of light reflections detected by the close detector and the far detector. The system is further configured to operate in a low power mode to generate a low intensity light pulse, and detect a close reflection of the low intensity light pulse with the close detector. An SpO2 is then determined based on the close reflection of the low intensity light pulse and the calibration factor.

Abstract: A system for monitoring medical conditions includes a conformable medical monitoring device that includes a first substrate layer, which includes an electronics module, many signal traces, and at least one electrode, such that one or more of the many signal traces electrically couple the at least one electrode to the electronics module. The conformable medical monitoring device includes a second substrate layer positioned over the electronics module, the first substrate layer, or any combination thereof to insulate the electronics module, the first substrate layer, or any combination thereof. The conformable medical monitoring device also includes a third substrate layer positioned over the second substrate layer, such that the third substrate layer reduces electromagnetic interference caused by a voltage pulse and includes an adjustable system coupled to the first substrate layer and that changes a position of the at least one electrode relative to the electronics module.

Abstract: A system includes a conformable biopotential sensor that withstands a defibrillation pulse. The conformable biopotential sensor includes a polymer substrate, a plurality of electrodes printed on the polymer substrate, a signal trace printed on the polymer substrate, and one or more resistors printed on the polymer substrate and in electrical communication with an electrode of the plurality of electrodes via the signal trace. One or both of the one or more resistors and the polymer substrate withstand a defibrillation pulse. The conformable biopotential sensor further includes a coating layer applied to the one of both of the one or more resistors, wherein the coating is more thermally conductive than the polymer substrate.

Abstract: A wireless patient monitoring system includes a sensing device having a sensor that senses a physiological signal of a patient, an analog-to-digital converter that generates a stream of digitized signal samples based on the physiological signal, and a first processor. Each sensing device further includes a transmission management module executable on the first processor to divide the stream of digitized signal samples into two or more interlaced subsets containing non-adjacent signal samples from the stream of digitized signal samples, generate at least one subset packet based on each of the two or more interlaced subsets, and control wireless transmission of the subset packets. The system further includes a receipt management module executable on a second processor to receive the subset packets, extract each of the two or more interlaced subsets of non-adjacent signal samples, and piece the non-adjacent signal samples together to reconstruct the stream of digitized signal samples.

Abstract: In electrosensory vibration technology, a potential difference is formed between a touched surface of a device and a body member of a user, creating an attractive force between the two. To meet industry safety standards, the capability of a corresponding voltage source to drive electrical current may be kept low, and the maximum slew rate with such a voltage source would be accordingly limited. However, such a limit on the slew rate may result in softer haptic effects or lower repetition rates of haptic effects, and the ability of such a device to express a wide range of haptic effects may be reduced compared to a device capable of driving the external load with the maximum current allowed by applicable standards. As a technical means to solve this technical problem, it may be helpful to use a powerful voltage source with a controller to control the outgoing current.

Abstract: In electrosensory vibration technology, a potential difference is formed between a touched surface of a device and a body member of a user, creating an attractive force between the two. To meet industry safety standards, the capability of a corresponding voltage source to drive electrical current may be kept low, and the maximum slew rate with such a voltage source would be accordingly limited. However, such a limit on the slew rate may result in softer haptic effects or lower repetition rates of haptic effects, and the ability of such a device to express a wide range of haptic effects may be reduced compared to a device capable of driving the external load with the maximum current allowed by applicable standards. As a technical means to solve this technical problem, it may be helpful to use a powerful voltage source with a controller to control the outgoing current.

Abstract: The invention relates to the determination of the clinical state of a subject. A respective adaptive transform is applied to at least one measurement signal acquired from the subject, each adaptive transform being dependent on previously acquired history data, and a diagnostic index is formed, which is dependent on the transformed measurement signal(s) and serves as a measure of the clinical state of the subject. In order to reliably evaluate the clinical state of a subject on a fixed diagnostic scale during changes in the state of the subject, some or all of the previously acquired history data on which an adaptive transform is currently dependent is replaced with other previously acquired history data when a predetermined event is detected. The predetermined event is indicative of a change in the respective measurement signal, and the introduction of the said other previously acquired history data sets the transform ready for the change.

Abstract: Method and pulse oximeter system for determining blood characteristics of a subject are disclosed. A pulse oximeter sensor for collecting plethysmographic data is also disclosed. In order to reduce the power consumption, time instants of systolic rises are estimated in at least one plethysmographic waveform of a subject and light emitting elements of a sensor are controlled according to the estimated time instants, thereby to collect signal samples from a plurality of plethysmographic waveforms of the subject during the systolic rises. A desired blood parameter, typically oxygen saturation, is then defined based on the signal samples collected during the systolic rises.

Abstract: An electrode system for the measurement of biopotential signals includes a substrate. A microelectrode is coupled to the substrate. An accelerometer is coupled to the substrate. A biopotential amplifier is electrically coupled to the microelectrode and acceleration measurement circuit is electrically coupled to the accelerometer. A method of measuring a biopotential from a patient includes sensing a biopotential with a microelectrode. The biopotential is amplified with an amplifier in electrical communication with the microelectrode. A movement of the electrode is sensed with an accelerometer integrated with the electrode substrate. The sensed biopotential and the sensed movement are provided to an electronic controller. Portions of the sensed biopotential that correspond to sensed movement are identified as artifact contaminated portions.

Abstract: The invention relates to a method and apparatus for assessing the reactivity observable in a certain physiological signal, especially the EEG signal, of a comatose subject. In order to obtain an objective and a reliable measure of the reactivity automatically and without the presence of a trained EEG specialist, a valid signal model is constructed for an EEG signal obtained from the subject. A time reference corresponding to a stimulus is applied and further signal data is obtained from the time series, the further signal data being subsequent to the time reference. By employing the further signal data, the method tests whether the signal model remains to be a valid signal model for the EEG signal also after the stimulus, and indicates, based on the test, whether reactivity is present in the physiological signal.

Abstract: The invention relates to a method and apparatus for assessing the reactivity observable in a certain physiological signal, especially the EEG signal, of a comatose subject. In order to obtain an objective and a reliable measure of the reactivity automatically and without the presence of a trained EEG specialist, a time reference corresponding to a stimulus is detected and the physiological signal data obtained from the subject is aligned with the time reference. Two sets of values are determined for a measure indicative of the amount of irregularity in the physiological signal data, both sets including at least one value of the said measure and having defined positions with respect to the time reference in time domain. Based on the two sets, the apparatus determines whether reactivity is present in the physiological signal data.